These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36151847)

  • 1. Assessing potassium levels in critically ill patients with heart failure: application of a group-based trajectory model.
    Lin Z; Zheng J; Liu X; Hu X; Fuxian R; Gao D
    ESC Heart Fail; 2023 Feb; 10(1):57-65. PubMed ID: 36151847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between serum sodium level trajectories and survival in patients with heart failure.
    Xia YM; Wang S; Wu WD; Liang JF
    ESC Heart Fail; 2023 Feb; 10(1):255-263. PubMed ID: 36193558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association between serum potassium levels and all-cause mortality in patients with acute heart failure].
    Huang BP; Zhou Q; Zhao L; Zhao XM; Zhai M; Tian PC; Liang L; Huang LY; Feng JY; Zhang YH; Huang Y; Zhang J
    Zhonghua Yi Xue Za Zhi; 2023 Mar; 103(10):727-732. PubMed ID: 36889685
    [No Abstract]   [Full Text] [Related]  

  • 4. Dyskalemia in people at increased risk for heart failure: findings from the heart 'OMics' in AGEing (HOMAGE) trial.
    Monzo L; Ferreira JP; Cleland JGF; Pellicori P; Mariottoni B; Verdonschot JAJ; Hazebroek MR; Collier TJ; Cuthbert JJ; Pieske B; Edelmann F; Petutschnigg J; Khan J; Ahmed FZ; Girerd N; Bozec E; Díez J; González A; Clark AL; Cosmi F; Staessen JA; Heymans S; Rossignol P; Zannad F
    ESC Heart Fail; 2022 Dec; 9(6):4352-4357. PubMed ID: 36065795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled.
    Ferreira JP; Zannad F; Butler J; Filipattos G; Ritter I; Schüler E; Kraus BJ; Pocock SJ; Anker SD; Packer M
    Eur Heart J; 2022 Aug; 43(31):2984-2993. PubMed ID: 35687107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of dyskalemia at admission and early dyskalemia correction on survival and cardiac events of critically ill patients.
    Bouadma L; Mankikian S; Darmon M; Argaud L; Vinclair C; Siami S; Garrouste-Orgeas M; Papazian L; Cohen Y; Marcotte G; Styfalova L; Reignier J; Lautrette A; Schwebel C; Timsit JF;
    Crit Care; 2019 Dec; 23(1):415. PubMed ID: 31856891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK.
    Linde C; Qin L; Bakhai A; Furuland H; Evans M; Ayoubkhani D; Palaka E; Bennett H; McEwan P
    ESC Heart Fail; 2019 Apr; 6(2):280-290. PubMed ID: 30629342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of serum potassium in patients hospitalized for acute heart failure.
    Lombardi CM; Carubelli V; Peveri G; Inciardi RM; Pagnesi M; Ravera A; Tomasoni D; Garafa E; Oriecuia C; Specchia C; Metra M
    ESC Heart Fail; 2022 Aug; 9(4):2357-2366. PubMed ID: 35543336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypokalaemia and outcomes in older patients hospitalized for heart failure.
    Valentova M; Patel S; Lam PH; Faselis C; Arundel C; Fonarow GC; Cheng Y; Allman RM; von Haehling S; Anker SD; Ahmed A
    ESC Heart Fail; 2020 Jun; 7(3):794-803. PubMed ID: 32319205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypokalaemia and subsequent hyperkalaemia in hospitalized patients.
    Crop MJ; Hoorn EJ; Lindemans J; Zietse R
    Nephrol Dial Transplant; 2007 Dec; 22(12):3471-7. PubMed ID: 17848395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data.
    Krogager ML; Torp-Pedersen C; Mortensen RN; Køber L; Gislason G; Søgaard P; Aasbjerg K
    Eur Heart J; 2017 Jan; 38(2):104-112. PubMed ID: 28158516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term prognosis of normalising serum potassium following an episode of hypokalaemia in patients with chronic heart failure.
    Aldahl M; Polcwiartek C; Davidsen L; Kragholm K; Søgaard P; Torp-Pedersen C; Krogager ML
    Eur J Prev Cardiol; 2021 Apr; 28(3):316-323. PubMed ID: 33891686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease.
    Pitt B; Bushinsky DA; Kitzman DW; Ruschitzka F; Metra M; Filippatos G; Rossignol P; Du Mond C; Garza D; Berman L; Lainscak M;
    ESC Heart Fail; 2018 Jun; 5(3):257-266. PubMed ID: 29369537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum potassium and outcomes in heart failure with preserved ejection fraction: a post-hoc analysis of the PARAGON-HF trial.
    Ferreira JP; Claggett BL; Liu J; Desai AS; Pfeffer MA; Anand IS; van Veldhuisen DJ; Kober L; Cleland JGF; Rouleau JL; Packer M; Zile MR; Shi VC; Lefkowitz MP; Shah SJ; Vardeny O; Zannad F; Solomon SD; McMurray JJV
    Eur J Heart Fail; 2021 May; 23(5):776-784. PubMed ID: 33609066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term mortality and trajectory of potassium measurements following an episode of acute severe hyperkalaemia.
    Gorriz JL; D'Marco L; Pastor-González A; Molina P; Gonzalez-Rico M; Puchades MJ; Sanchis I; Escudero V; Estañ N; de la Espriella R; Nuñez E; Pallardó L; Núñez J
    Nephrol Dial Transplant; 2022 Feb; 37(3):522-530. PubMed ID: 33508124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum potassium in elderly heart failure patients as a predictor of readmission within 1 year.
    Shang G; Gao Y; Liu K; Wang X
    Heart Vessels; 2023 Apr; 38(4):507-516. PubMed ID: 36318301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of hypo and hyperkalaemia in acute heart failure with reduced ejection fraction. Analysis of cardiovascular mortality and hospital readmissions.
    Laymito-Quispe RDP; López-Vilella R; Sánchez-Lázaro I; Donoso-Trenado V; Lozano-Edo S; Martínez-Dolz L; Almenar-Bonet L
    Med Clin (Barc); 2022 Mar; 158(5):211-217. PubMed ID: 34229884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin-converting enzymes/angiotensin receptor blockers: results from AMETHYST-DN.
    Pitt B; Bakris GL; Weir MR; Freeman MW; Lainscak M; Mayo MR; Garza D; Zawadzki R; Berman L; Bushinsky DA
    ESC Heart Fail; 2018 Aug; 5(4):592-602. PubMed ID: 29767459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of serum sodium levels across different serum potassium levels in heart failure patients: A Danish register-based cohort study.
    Polcwiartek C; Hansen SM; Kragholm K; Krogager ML; Aldahl M; Køber L; Torp-Pedersen C; Jensen SE; Søgaard P
    Int J Cardiol; 2018 Dec; 272():244-249. PubMed ID: 30139700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience using high-dose glucose-insulin-potassium (GIK) in critically ill patients.
    Slob EMA; Shulman R; Singer M
    J Crit Care; 2017 Oct; 41():72-77. PubMed ID: 28500918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.